In a review article by Notaro and al., the authors suggested a dual-inhibition approach to prevent C3 binding to red blood cells, thereby reducing extravascular hemolysis and preventing massive breakthrough hemolysis in PNH patients [96]. The gene discussed is C3; the disease is paroxysmal nocturnal hemoglobinuria.